Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

IL3R Directed Agents, SL-401 and SL-501, Inhibit the Growth of Leukemia Stem Cells In CML.

Olga Frolova, MD, PhD, Arthur E Frankel, MD, Borys Korchin, MD, PhD, Jorge Cortes, MD, Hagop M. Kantarjian, MD, Michael Andreeff, MD, Ph.D., Marina Konopleva, MD, PhD

Blood (2010) 116 (21): 3403.

https://doi.org/10.1182/blood.V116.21.3403.3403

Published: 2010

Journal Articles

Role of Hypoxia and Hypoxia-Inducible-Factor 1α (HIF1A) In the BM Microenvironment-Mediated Protection of Leukemic Cells.

Rodrigo Jacamo, Juliana Benito, Ph.D., Olga Frolova, MD, PhD, Ye Chen, Hongbo Lu, MMSC, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD

Blood (2010) 116 (21): 2586.

https://doi.org/10.1182/blood.V116.21.2586.2586

Published: 2010

Journal Articles

Therapeutic Targeting of the Hypoxic Microenvironment in Acute Lymphocytic Leukemia.

Marina Konopleva, MD, PhD, Juliana Benito, PhD, Yue-Xi Shi, Sergej Konoplev, MD, PhD, Steven M. Kornblau, MD, Olga Frolova, MD, PhD, Patrick A. Zweidler-McKay, MD, PhD, YiHua Qiu, MD, MS, William R. Wilson, PhD, Dario Campana, MD, PhD, Rodrigo Jacamo, PhD, Hongbo Lu, MMSC, Wendy Fang, MD, Gautam Borthakur, MD, Carlos E. Bueso-Ramos, MD, Hagop M. Kantarjian, MD, Deborah A. Thomas, MD, Michael Andreeff, MD, PhD

Blood (2009) 114 (22): 2040.

https://doi.org/10.1182/blood.V114.22.2040.2040

Published: 2009

Journal Articles

Targeting IL3 Receptor in Chronic Myeloid Leukemia.

Olga Frolova, MD, PhD, Rui-Yu Wang, MD, PhD, Borys Korchin, Julie C. Watt, Jorge Cortes, MD, Arthur E. Frankel, MD, Hagop M. Kantarjian, MD, Michael Andreeff, MD, PhD, Marina Konopleva, MD, PhD

Blood (2009) 114 (22): 2172.

https://doi.org/10.1182/blood.V114.22.2172.2172

Published: 2009

Journal Articles

Targeting the Hypoxic Microenvironment by mTOR Inhibitors Sensitizes ALL Cells to Chemotherapy

Olga Frolova, MD, PhD, Ismael J. Samudio, PhD, Zakar H. Mnjoyan, PhD, Hongbo Lu, Sergej Konoplev, MD, PhD, Deborah A. Thomas, MD, Hagop M. Kantarjian, MD, Elizabeth J. Shpall, MD, Michael Andreeff, MD, PhD, Marina Konopleva, MD, PhD

Blood (2008) 112 (11): 18.

https://doi.org/10.1182/blood.V112.11.18.18

Published: 2008

Journal Articles

Relationship between mTOR-Mediated Upregulation of Glycolysis and Chemosensitivity of ALL Blasts.

Olga Frolova, MD, PhD, Daniela Buglio, Ph.D., Ismael Samudio, Ph.D., Teresa McQueen, Hagop Kantarjian, M.D., Mary A. Weiser, M.D., Ph.D., Michael Andreeff, M.D., Ph.D., Marina Konopleva, M.D., Ph.D.

Blood (2006) 108 (11): 1833.

https://doi.org/10.1182/blood.V108.11.1833.1833

Published: 2006

Journal Articles

Immunomodulatory Effects of the Triterpenoid CDDO after Allogeneic Bone Marrow Transplantation in Mice: Reduction of Acute Graft-Versus-Host Disease Lethality.

William J. Murphy, PhD, Olga Frolova, MD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD, Weihong Ma, MD, Danice Wilkins, Lisbeth A. Welniak, PhD, Kai Sun, MD, PhD

Blood (2005) 106 (11): 1316.

https://doi.org/10.1182/blood.V106.11.1316.1316

Published: 2005

NARROW

IL3R Directed Agents, SL-401 and SL-501, Inhibit the Growth of Leukemia Stem Cells In CML.

Role of Hypoxia and Hypoxia-Inducible-Factor 1α (HIF1A) In the BM Microenvironment-Mediated Protection of Leukemic Cells.

Therapeutic Targeting of the Hypoxic Microenvironment in Acute Lymphocytic Leukemia.

Targeting IL3 Receptor in Chronic Myeloid Leukemia.

Targeting the Hypoxic Microenvironment by mTOR Inhibitors Sensitizes ALL Cells to Chemotherapy

Relationship between mTOR-Mediated Upregulation of Glycolysis and Chemosensitivity of ALL Blasts.

Immunomodulatory Effects of the Triterpenoid CDDO after Allogeneic Bone Marrow Transplantation in Mice: Reduction of Acute Graft-Versus-Host Disease Lethality.

Email alerts

ASH Publications

American Society of Hematology

IL3R Directed Agents, SL-401 and SL-501, Inhibit the Growth of Leukemia Stem Cells In CML.

Role of Hypoxia and Hypoxia-Inducible-Factor 1α (HIF1A) In the BM Microenvironment-Mediated Protection of Leukemic Cells.

Therapeutic Targeting of the Hypoxic Microenvironment in Acute Lymphocytic Leukemia.

Targeting IL3 Receptor in Chronic Myeloid Leukemia.

Targeting the Hypoxic Microenvironment by mTOR Inhibitors Sensitizes ALL Cells to Chemotherapy

Relationship between mTOR-Mediated Upregulation of Glycolysis and Chemosensitivity of ALL Blasts.

Immunomodulatory Effects of the Triterpenoid CDDO after Allogeneic Bone Marrow Transplantation in Mice: Reduction of Acute Graft-Versus-Host Disease Lethality.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only